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Abstract — The different isoforms of transferrin have been quantified by isoelectric focusing in the sera
of psoriasis patients with and without a history of abusing alcohol. In both male and female psoriasis
subjects abusing alcohol, there were significant increases in the 2-sialylated forms by comparison to the
control subjects. Psoriasis patients who had no evidence of alcohol abuse had similar profile for the
isoforms of transferrin to that of the controls. Other groups of patients with alcohol-induced tissue
damage, i.e. liver, brain or muscle, used as positive controls, similarly showed significant increases in the
2-sialylated forms, by comparison to controls. These results substantiate the current use of carbohydrate-
deficient transferrin as a sensitive marker of alcohol abuse, particularly in subjects not drinking in excess
of 60 g of ethanol/day but showing alcohol-related psoriasis.
INTRODUCTION
In Western society, alcohol abuse has a prevalence
of between 10 and 15% in the population. Within
this small section, there is a striking variability in
an individual's response to the effects of excessive
alcohol intake. A variety of symptoms will be
exhibited by these subjects ranging from life-
threatening alcohol induced liver damage or brain
damage, to cardiovascular disturbances, myopathy
or merely skin disorders. Alcohol abuse is now
recognized to precipitate or exacerbate certain
cutaneous diseases, in particular psoriasis (Higgins
and du Vivier, 1992 and 1994), and these skin
problems appear to occur as an early manifesta-
tion, often before evidence of classical hepatic
toxicity is apparent. A recent survey of 100
psoriasis patients attending the Dermatology
Out-patients' Department of a London Teaching
Hospital showed that 39 of these patients were
abusing alcohol to a limited extent, marginally
exceeding the recommended alcohol intake of 21
units/week for men and 14 units/week for women.
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Only three subjects had any features of depen-
dency (Higgins et ai, 1992). On cessation of
alcohol intake the psoriasis improved.
There has been much interest to establish a
biochemical test which will identify subjects
abusing alcohol. Over the past 20 years, the use
of the carbohydrate-deficient transferrin assay,
which quantifies the degree of sialylation of
transferrin, particularly the di- (2-Si), mono- (1-
Si) and asialylotransferrin (collectively termed
carbohydrate-deficient transferrin, CDT), has
shown both specificity and sensitivity, in identify-
ing individuals severely abusing alcohol. How-
ever, in the few studies of this parameter in the
sera of individuals who abuse alcohol to a limited
degree, the suitability of this biochemical marker
to identify the abusers of alcohol has been
questionable.
We have therefore assessed in these present
studies the degree of sialylation of transferrin in
male and female subjects with psoriasis, who have
an intake of alcohol marginally above the
recommended guidelines, and compared these
results with another group of psoriatic patients
with no evidence of abusing alcohol. Patients with
alcohol-induced pathologies (myopathy, brain
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damage and liver damage) induced by excessive
alcohol intake, have been used as positive
controls.
MATERIALS AND METHODS
Selection of patients
Psoriasis patients. Patients (n = 52) were
recruited from the Dermatology Out-patients'
Department at King's College Hospital, London,
UK as part of a prospective study examining the
relationship between alcohol consumption and
skin disease. Drinking habits were assessed by
means of a frequency/quantity questionnaire
(Bernhadt et al., 1982). Of these 52 patients,
four females and 18 males were identified as
heavy drinkers (the mean intake of alcohol was
36 ± 17 units/week, or 284 ± 136 g alcohol/
week). Each of these subjects was abusing alcohol
at the time of the study.
Patients with alcohol-induced liver cirrhosis or
myopathy. Patients with alcohol-induced cirrhosis
(n = 6) or alcoholic myopathy (n = 6), which had
been confirmed by liver and muscle biopsy,
respectively, were consuming alcohol up to the
time of the blood sampling (mean intake of
alcohol/week 295 ± 30 units or 2360 ± 240 g
alcohol/week), and were selected as positive
controls for alcohol abuse.
Patients with alcohol-induced brain damage.
Patients with alcohol-induced brain damage
(n = 6), which had been confirmed by both
biochemical (altered parameters for the erythro-
cyte transketolase enzyme) and cognitive tests,
were also tested. Such subjects were not necessar-
ily drinking at the time of blood sampling.
Control subjects. Healthy individuals (n = 10)
were recruited for the study, with an age range
comparable to the patient groups. These controls
consumed only small quantities of alcohol per
week (<4 units).
Methods
Carbohydrate-deficient transferrin. Sera were
prepared from the blood specimens collected
from the control and different patient groups,
and were stored at -20°C until analysis. Iso-
electric focusing was by the previously described
methodology (de Jong and van Eijk, 1988).
Essentially serum (50 u.1) was incubated with
2nl of 0.5 M NaHCO3 and 2ul of 10 mM
Fe{III) citrate for a few minutes at room
temperature prior to its application to the Phast-
System with Immobiline Dry Plate pH 4-7
(Pharmacia LKB, Uppsala, Sweden) with a
pH gradient between the electrodes of 5.0-6.0.
For the visualization of the separated transferrin
bands 200 ul anti-Tf IgG (Dako IgG a/s, Copenha-
gen, Denmark; titre 1080) were spread over the
surface of the gel immediately at the completion
of the run and left to incubate at room temperature
for 20 min. All other serum proteins were removed
from the gel by washing the gel in 0.15 M saline
for 48 h at 4°C with several changes of the saline.
The gel was incubated with 200 g/1 trichloroacetic
acid and stained with Coomassie Brilliant Blue
R-250, 1 g/1, at 50°C for 10 min. The gel was
destained at 20°C. The purified sialic-acid-
depending transferrin bands were quantified with
an Ultroscan XL densitometer (He/Nelaser,
633 nm, Pharmacia, Sweden), connected to a
personal computer with GelScan XL software
(version 2.1, Pharmacia, Sweden).
Statistical analysis
Statistical analysis was by ANOVA with pro-
tected Tukey /-test.
RESULTS
Table 1 shows the results for the different
isoforms of transferrin in sera of patients with
psoriasis. There were small and insignificant
changes in the percentages of isoforms of the
highly sialylated form of transferrin present, while
there were significant increases in the percentage
of the 2-Si form present in the sera of psoriasis
patients abusing alcohol, both male and female, by
comparison to control subjects. In addition, the 3-
Si form was also increased in the female psoriatic
patients abusing alcohol. The profiles for the
isoforms of transferrins in the patients with
psoriasis not abusing alcohol were comparable to
the controls.
Each of the patient groups in whom excessive
amounts of alcohol had induced tissue damage
(liver, brain or muscle) showed significantly
increased percentages of the 2-sialylated forms
of transferrin (Table 2). The increase in the
2-sialylated form in each of these groups appeared
to be at the expense of the 6-Si (apart from liver-
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Table 1. Isoforms of transferrin (%) in sera of psoriasis patients and controls
Subjects
Transferrin isoforms
7-Si 6-Si 5-Si 4-Si 3-Si 2-Si
Psoriasis patients
Male (n = 20)
Female (n = 18)
Abusing alcohol
Male (n = 10)
Female (/i = 4)
Control subjects (n = 10)
0.66 ± 0.39 3.88
0.52 ± 0.23 4.90
0.60 ± 0.36 4.19
n/d 4.48
n/d 4.92
1.1
1.14
20.9
23.6
0.87 20.4
1.76 23.8
1.70 25.6
2.9
3.34
2.15
3.79
1.70
63.9
60.8
63.9
56.9
60.6
4.6
4.0
5.5
6.76
6.%
7 13
7.49
10.23
2.29
2.29
3.1
1.80'
2.7
2.98
3.42
4.68
2.6 6.56 ± 1.83 2.23 + 0.47
1.34
1.06
2.69'
0 . 6 7 "
Results are mean ± SD. Statistical significance by ANOVA with protected Tukey r-test:
comparison to control subjects, n/d Denotes not detectable.
*P < 0.05, **P < 0.01 by
damaged patients) and 5-Si isoforms of transferrin,
which were both decreased.
DISCUSSION
In this present study, both male and female
psoriasis patients who marginally abused alcohol
had significantly elevated levels of the 2-Si form
of CDT, whereas the 3-Si form was also elevated
in female subjects. Patients with psoriasis who did
not abuse alcohol showed similar profiles for the
isotransferrins to that of the controls. This study
has also confirmed the large elevation of di-
sialylated transferrin in dependent alcoholic
patients with alcoholic liver disease and brain
damage.
Earlier procedures used non-quantitative meth-
ods of isoelectric focusing, as reported in this
present communication, while more recently,
quantitative methods have been developed to
separate transferrin components above pi 5.65 by
micro-anion-exchange chromatography (Stibler et
al., 1986) followed by radioimmunoassay (RIA) to
evaluate CDT. This latter method has been further
modified by adoption of a different elution buffer
that achieves a more stable anion-exchange
chromatography of isotransferrins. Studies which
have compared isoelectric focusing and anion
exchange chromatography (e.g. Schellenberg et
al., 1989; Xin et al., 1992; Lof et al., 1993; Anton
and Bean, 1994) have found a somewhat higher
sensitivity and specificity with isoelectric focusing
immunofixation than with the anion-exchange
chromatogTaphy-RIA method. In addition, the
analysis of CDT by anion-exchange chromatogra-
phy will also suffer from the fact that total
transferrin concentration is somewhat variable
among individuals regardless of whether or not
they are alcoholic, while the presence of anti-
coagulants in the sample may interfere with the
chromatographic procedure.
There have been numerous studies investigating
the suitability of CDT as a pertinent marker of
alcohol abuse. Sensitivity and specificity
> 70-80% for alcohol misusers have been identi-
fied, particularly in patients with liver cirrhosis
Table 2.
Subjects
Isoforms of transferrin (%)ir
7-Si
i sera of alcohol
6-Si
misusers with myopathy
Transferrin
5-Si
, liver or brain damage,
isoforms
4-Si 3-Si
and healthy controls
2-Si
Alcohol misusers
Liver damage (n = 6)
Myopathy (n = 6)
Brain damage (n = 6)
Control subjects (n = 10)
n/d
n/d
n/d
n/d
5.16 ± 1.39
3.05 ± 1.09
3.2 ± 0.32
4.92 ± 1.36
20.9 ± 3.9
17.7 ± 6.2
20.18 ± 2.36
25.6 ± 1.70
59.1 ± 5.3
64.2 ± 5.7
62.9 ±3 .13
60.6 ± 2.6
7.72 ± 2.3
7.3 ± 1.8
8.33 ± 1.53
6.56 ± 1.83
6.58 ± 4 . 8 6 "
4.5 ± 2 .3 '
5.4 ± 3.0*
2.23 ± 0.47
Results are mean ± SD. Statistical significance by ANOVA with protected Tukey Mest: *P < 0.05, **P < 0.01 by
comparison to control subjects, n/d Denotes not detectable.
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(Stauber et al., 1995) or recently consuming large
amounts of alcohol (Lesch et al., 1996a). The
most critical unresolved question is what exact
parameters are needed to alter the CDT levels, e.g.
how much alcohol needs to be consumed, what is
the duration of the drinking history needed and
does there have to be associated tissue damage? In
the few studies where CDT values have been
assayed in healthier and younger alcohol misusers
with shorter drinking histories, CDT has been
shown to have a sensitivity of <30% (Takase et
al., 1985). Furthermore, in one study, only 20% of
normal subjects consuming 60 g/day for 3 weeks
showed CDT levels that exceeded the upper
normal level (Salmela et al., 1994), while no
elevation of CDT was evident in control subjects
consuming 80 g alcohol/day for 3 weeks (Lesch et
al., 19966). Such results have led to the belief that
it is necessary for there to be some degree of
physical damage before CDT is elevated (Takase
et al., 1985; Bisson and Milford-Ward, 1994). In
addition, in one study, female alcohol abusers
were shown to have a lower specificity and
sensitivity for CDT than male abusers (Anton
and Moak, 1994), although this was not confirmed
in this present study. The few female psoriatic
patients abusing alcohol showed highly elevated
amounts of 2-Si CDT. A study of 439 treated
hypertensives showed that there was a relationship
between CDT and high alcohol intake, the
sensitivity of the test being 87%, but there was a
considerable number of false positives (Fagerberg
et al., 1994a). Serum CDT concentrations were
also associated with insulin sensitivity (Fagerberg
et al., 19946) indicating that factors related to
insulin may be operative.
The iron-binding protein transferrin plays an
important role in iron homeostasis, binding to
transferrin receptors on cell surfaces prior to
internalization and release of iron into the cell. It
remains unclear as to whether excessive alcohol
consumption actually alters iron homeostasis. It is
clear that alcohol will increase gut permeability,
and possibly increases absorption of iron into the
enterocyte (Thomson et al., 1995) and therefore
iron uptake. There was a twofold increase in the
mean concentration of serum ferritin in the
psoriasis patients with increased alcohol intake
by comparison to the non-drinking psoriasis group
(165.9 ± 146 vs 87.8 ± 6.75 ng/1 respectively),
although only five of the former group had values
for ferritin increased above the normal range
(unpublished results). Other diseases where there
are perturbations of iron metabolism have been
Investigated, to ascertain whether changes also
occur in the transferrin isoforms. Patients with
haemochromatosis (increased serum ferritin
levels) showed marginally increased CDT values,
particularly during phlebotomy (Jensen et al.,
1994), although the values at this time were not
necessarily elevated above the reference range.
Iron deficiency caused either as a normal physio-
logical response to pregnancy (decreased serum
ferritins) or as a result of chronic inflammation
(increased serum ferritin), as observed in rheuma-
toid arthritis patients, showed a tendency for an
increase in the highly sialylated transferrins, rather
than the disialotransferrin which maintained a
constant value (de Jong, 1993).
These studies have indicated that CDT is a
sensitive marker of alcohol intake in subjects not
necessarily showing gross physical damage. CDT
may therefore prove to be an effective marker of
early alcohol misuse, possibly before the onset of
irreversible organ damage. Although other mar-
kers of alcohol abuse show high specificity and
sensitivity either alone or in combination, such as
apo A-II, plasma y-GT, plasma uric acid and MCV
(Burke et al., 1992), the simplicity of a single test
to assess alcohol abuse remains attractive. Further
studies are required to identify what role these
different isoforms of transferrin may play within
biochemical systems.
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